Global Hepatitis E Diagnostic Tests Market: Pricing Strategies of Players to Drive up Competition

A handful of companies dominate the global market for hepatitis E diagnostic tests. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., among them, is the dominant player that accounts for around 30% of market share. The other key players in the market are Fortress Diagnostics, Mikrogen, Biokit SA, MP Biomedicals, Altona Diagnostics, and Fast-track Diagnostics. Competition among them is robust and going forward is slated to intensify further on account of competitive pricing strategies leveraged by them.

There is just a small proportion of products have been approved for commercial use in the global market for hepatitis E diagnostic tests. In fact, all products in the U.S. serve only research purposes. On account of a lesser number of products available, the bargaining power of buyers is relatively limited in the market.

This 162 page report gives readers a comprehensive overview of the Hepatitis E Diagnostic Tests Market .Browse through 18 data tables and 55 figures to unlock the hidden opportunities in this market.
http://www.transparencymarketresearch.com/hepatitis-e-diagnostic-tests-market.html

A report by Transparency Market Research forecasts the global market for hepatitis E diagnostic tests to attain a value of US$60.43 mn by 2024-end, rising at a steady CAGR of 3.8%.

Periodic Outbreaks of Hepatitis E Propels Asia Pacific Market

The different types of hepatitis E diagnostic tests are ELISA HEV IgM, ELISA HEV IgG, RT-PCR, etc. Among them, ELISA IgM kits is predicted to see maximum rise in demand in the foreseeable future on account of its use in detection of acute hepatitis E infections. Initiatives to raise awareness among people is also expected to stoke demand. This segment is expected to expand at a CAGR of 4.2% from 2016 to 2024.

Based on geography, the key segments of the global market for hepatitis E diagnostic tests are North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. Asia Pacific, of them, dominates the market with maximum share which is predicted to increase further to 48.4% by the end of 2024. Stellar performance in the market in the region has been brought about by hyper-endemic sero-prevalence of the disease in South and East Asia, periodic outbreaks of the malady, and its high prevalence among pregnant women.

Rising Prevalence of Hepatitis E Drives Market

The most prominent growth driver in the global market for hepatitis E diagnostic tests is the high prevalence of hepatitis E worldwide. As per WHO, about 20 million HEV infections happen annually, worldwide, of which round 3.3 million develop into symptomatic cases. Besides, increase is global tourism has also upped the occurrence of hepatitis E as people travelling to regions where the disease is endemic or hyperendemic often contract for it can be spread through consumption of contaminated water.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Hepatitis E Diagnostic Tests Market during 2016-2024. http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16859

Asymptomatic Nature of Hepatitis E Counters Poses Roadblock

Countering the growth in the market is the fact that most of those afflicted with hepatitis E are asymptomatic, which makes it difficult to detect the disease. False reactivity to tests is also hobbling the market. Explains the lead analyst of the report, “Though serological tests are the most commonly used tests for the diagnosis of hepatitis E infections, the false reactivity of these tests might lead to a decline in the demand for these test kits in the future. The HEV-IgM tests have shown false-positive reactions against Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in various research studies. These false-positive results due to EBV- and/or CMV-IgM cross-reactivity indicates that serological tests might be unreliable for the diagnosis of HEV infections. This might have a negative impact on the sale of HEV diagnostic kits as IgM is one of the more significant test kits in the HEV diagnostic tests market.”

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.